Costochondritis Management

Diagnosis and Characteristics

Costochondritis is characterized by tenderness of costochondral joints and localized chest pain that may be reproduced by palpation, with absence of swelling, redness, or warmth, distinguishing it from Tietze syndrome 1, 2

It's essential to rule out more serious causes of chest pain, including acute coronary syndrome, pulmonary embolism, aortic dissection, pneumothorax, pericarditis, and pneumonia, which can be distinguished through proper evaluation and diagnostic tests 1, 2

The American Heart Association and the American College of Cardiology recommend nonsteroidal anti-inflammatory drugs (NSAIDs) at maximum tolerated dosage for 1-2 weeks to reduce inflammation and pain, with options including ibuprofen, naproxen, diclofenac, and celecoxib 1, 2, 3, 4
Topical NSAIDs can be considered as an alternative with fewer systemic side effects, according to the American Family Physician 5
Acetaminophen can be considered as an alternative if NSAID rotation is ineffective, and small doses of non-acetylated salicylates can be considered if both NSAIDs and acetaminophen are ineffective, as recommended by the American Family Physician 6
A short course of oral corticosteroids or intra-articular corticosteroid injections may be considered as bridging options if there is an insufficient response to NSAIDs after 2-4 weeks, as suggested by the Annals of the Rheumatic Diseases and the American College of Cardiology 3, 7

Applying local heat or cold to the affected area, with heat using a heating pad for 15-20 minutes several times daily, and cold applying ice wrapped in a towel for 10-minute periods, may provide pain relief, as recommended by the BMJ and the American Family Physician 6, 8
Relative rest and reduced activity that aggravates pain, and avoiding activities that involve muscle overuse, are recommended, as advised by the American Family Physician 6

Evaluate treatment response after 2-4 weeks, and if symptoms persist beyond 4-6 weeks despite appropriate treatment, consider further evaluation to rule out other causes 1, 2, 7
Follow-up should be scheduled in 2-4 weeks to assess response to therapy, as suggested by the Annals of the Rheumatic Diseases 7
Approximately 80% of patients can improve within 12 months with proper treatment, although the condition can be resistant to treatment and may require a combination approach 7

Gastrointestinal, renal, and cardiovascular risks associated with NSAIDs should be considered, particularly in elderly patients or those with comorbidities, as cautioned by the BMJ and the Journal of Crohn's and Colitis 4, 8
Long-term use of NSAIDs should be avoided due to potential risks, as advised by the Journal of Crohn's and Colitis 9